Chondroitin Market, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report ID: GMI3461

Summary Methodology

Increasing cases of osteoarthritis owing to rise in geriatric population and changing diet patterns deficient in calcium will boost chondroitin market demand. In the state of West Virginia, U.S. over 30% of all adults were diagnosed with arthritis in 2017. It is widely used in manufacturing supplements to treat pain, loss of cartilage & lubrication associated with the symptoms of bone diseases which will foster market growth.

Extreme cold climatic conditions in European countries and sedentary lifestyles will increase the chondroitin market demand. It is utilized in manufacturing supplements for bone strength as it is a major component of cartilage & helps in retention of water which is required for lubrication between joint membrane. In Italy, over 4,500 people were diagnosed with osteoporosis in 2017. It is manufactured from the cartilage of animals like pigs, shark, porcine, poultry, crocodile, cows, and other animals. Burgeoning health consciousness on bone health will trigger the growth of chondroitin based supplements.

Demand for chondroitin based dietary supplements will increasing owing to rise in healthcare expenditure & high consumer emphasis on preventive care & self-management methods. It is consumed as an alternative medicine to slow the progression of osteoarthritis. In Italy, over 9 million people diagnosed with either arthritis or osteoarthritis in 2017. It reduces pain & inflation by repairing damaged cartilage and provides a lubricating layer to reduce friction while performing day to day activities. It can also be used in the manufacturing of medicine for dry eyes which may stimulate market share.

Increasing consumer inclination to improve personal health issues such fibromyalgia, chronic joint pain, and inflammation may foster market growth. Supplement market in Italy was valued at over USD 30 billion in 2017. Chondroitin is widely used as prescription drug for osteoporosis as it helps in enriching cartilage loss and reduces friction between joints. Chondroitin supplements possess anti-inflammatory, lubricating, and water retention characteristics which may boost product demand.  

Increasing technological trends & dependence on electronics products such as mobiles, laptops, and other screen embedded gadgets will boost the market for chondroitin. Blue light emitted from screens & digital devices lead to eyestrain & weakening of retinal cells which may weaken eye cells. It is widely used in the manufacturing of eye drops for treating symptoms of dry eyes. In U.S. over 4 million people aged between 40-59 were diagnosed with cataract on 2017. The drug is approved by FDA & is used during cataract surgery as a solution for preserving corneas used for eye transplants which may foster market growth.

Increasing demand for nutraceuticals products may stimulate chondroitin market size. Growing consumer consciousness towards consumption of various supplements may drive the product growth. The product is utilized in calcium supplements as consumers with calcium deficiency in blood activates defense mechanism and reduces cartilage ratio from kneecaps may increase the risk for arthritis. The chondroitin market demand will increase owing to its anti-inflammation properties, ability to retain water which acts as lubricating medium reducing friction between joint membranes.

Chondroitin is also used in manufacturing medicines for cardiovascular diseases as its anti-inflammation properties strengthen heart muscles and reduce the risk of heart attacks which will foster market growth. It is also useful in treating cardiovascular problems such as irregular heartbeats, enlargement of heart muscles which may stimulate the product market share.

North America chondroitin market driven by the U.S., Canada, & Mexico may witness significant growth during the forecasted time period. Increasing research trends in advanced wound care market owing to growth in chronic diseases such as diabetes will boost the product demand. Development of new drugs & products specially in hard wound cases will foster market growth as chondroitin increases cell adhesion & cell proliferation which aid in recovering of wounds and reduces the risk of infection, which may in turn boost regional product growth.

Europe driven by UK, France, Germany, and Italy chondroitin market may witness substantial growth during foreseeable timeframe.  Rising cases of obesity among youth in the region has augmented focus towards healthy routines & products indorsing overall physical health and wellness. In Scotland, over 3% of population was diagnosed with cardiovascular stroke in 2017. Obesity act as a major reason in growing cases of hypertension, diabetes and cardiovascular diseases like stroke and coronary artery problems., owing to which consumers are preferring chondroitin based nutraceuticals products, which may stimulate the regional industry growth.

Asia Pacific driven by Japan, India and China chondroitin market demand may see significant growth over the projected time span. Increasing cases of obesity among youth globally has increased focus towards health lifestyles & dietary habits, & supplements promoting overall wellness, and physical health which will foster market share. In India, over 17% of the population was diagnosed with ischaemic heart disease in 2017. These factors are pushing consumers to try chondroitin based supplements as it helps in maintaining cardiovascular health and musculoskeletal fitness which will boost market share.

Global chondroitin market share is consolidated as market consist of few pivotal players. Companies such as Pacific Rainbow, TSI Group, Sioux Pharm, Synutra International, Nippon Zoki are key players in the market.

Chondroitin Market, By Application, 2014-2025 (Tons) (USD Million)

  • Supplements
  • Pharmaceuticals
  • Wound Healing
  • Others

Methyl Chondroitin Market, By End-Use, 2014-2025 (Tons) (USD Million)

  • Cardiovascular Health
  • Bone Health
  • Ophthalmological Health
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Poland
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Malaysia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Company Profiles:

  • Pacific Rainbow
  • TSI Group
  • Sioux Pharm
  • Synutra International
  • Nippon Zoki
  • ISBA
  • Huiwen
  • YBCC
  • Focus Chem



What Information does this report contain?

Historical data coverage: 2016 to 2020; Growth Projections: 2021 to 2027.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X